Good news for Tipperary CF sufferers

Details of a new €10.5 million construction development at the Mid Western Regional Hospital aimed at filling significant gaps in the provision of specialist services including cystic fibrosis were announced in Limerick last week.

Details of a new €10.5 million construction development at the Mid Western Regional Hospital aimed at filling significant gaps in the provision of specialist services including cystic fibrosis were announced in Limerick last week.

The development of a purpose built six storey building on the hospital's Dooradoyle campus represents a united effort by the Mid Western Hospitals Development Trust, the Parkinson's Association and the Cystic Fibrosis Association of Ireland. Planning permission for the development was received on December 23, 2010. Construction is due to begin in June 2011 and the various components of the project are expected to be operational by January 2013. Construction costs are estimated to be €10.5 million and additional funding is available for equipment.

Speaking in Limerick, at the launch, Mr Louis Creaven, chairman of the Mid Western Hospitals Development Trust, said -"Pressure on public finances means that the work of bodies such as the Parkinson's Association of Ireland and Cystic Fibrosis Association of Ireland, TLC4CF Mid-West Branch of Cystic Fibrosis Association and the Mid-Western Hospitals Development Trust, is today more important than ever in meeting the gaps in the public health service.

The facilities to be provided in the development include a Cystic Fibrosis Out Patients Unit with five treatment rooms and an in-patient unit with nine en suite rooms.

There will also be a Neurological Unit to cater for eleven neurological conditions. From the very young with epilepsy, all ages with Parkinson's, Multiple Sclerosis, Motor Neuron Disease and then the more common condition of stroke; a Dermatology Outpatient Centre to bring all dermatology services together at one location and to act as a focus for dramatic improvements in services for dermatology patients throughout the region; and a Symptomatic Breast Specialist Unit to consolidate services which are at present fragmented in different areas of the hospital.

Owen Kirby, Chairman of TLC4CF, commented: "This is a very positive move and a critical next step in TLC4CF's goal of achieving a world class facility for CF Adults in the Mid Western Regional Hospital. TLC4CF would also like to acknowledge the other very positive fact that the staff complement at MWRH dedicated to CF patients has increased as part of our overall drive.

The number of adult CF patients attending MWRH is increasing all the time as people living with CF are surviving longer. There is a dedicated Paediatric CF team there, but at present the facilities in the Med West for adults with CF are very basic. The presence of this new dedicated facility will go a long way to improving the longevity and quality of the lives of people living with CF in the Mid West region.

Sincere thanks are extended to all that have helped fund this initiative.